natgillin/translations-raw huggingface dataset:
The usual treatment duration of doripenem therapy ranges from 5-14 days and should be guided by the severity, site of the infection, infecting pathogen and the patient’s clinical response.
Običajno zdravljenje z doripenemom traja od 5-14 dni in je odvisno od resnosti in mesta okužbe, povzročitelja okužbe ter od bolnikovega kliničnega odziva.
The usually effective dose is 40 mg once daily.
Obiačjno učinkovit odmerek je 40 mg enkrat na dan.
The usually effective dose is 40 mg once daily.
Običajni učinkovit odmerek je 40 mg enkrat na dan.
The usually effective dose is 40 mg once daily.
Običajno učinkoviti odmerek je 40 mg enkrat na dan.
The vaccination course consists of two doses.
Cepimo z dvema odmerkoma.
The vaccination may cause a slight rise in body temperature (less than 1°C) for a transient period (less than 48 hours after injection) without any consequence to the health or performance of the animal.
Cepljenje lahko povzroči rahel dvig telesne temperature (manj kot 1 oC) v prehodnem obdobju (manj kot 48 ur po vnosu) brez kakršnihkoli posledic za zdravje ali proizvodno sposobnost živali.
The vaccination schedule depends on the age of the child and should be based on official recommendations: children aged between six weeks and six months are normally given four doses.
Shema cepljenja je odvisna od starosti otroka in mora temeljiti na uradnih priporočilih: otroci, stari od šest tednov do šest mesecev, običajno prejmejo štiri odmerke.
The vaccination schedule depends on the age of the subject.
Shema cepljenja je odvisna od starosti oseb.
The vaccination schedule for Synflorix depends on the age of the child and should be based on official recommendations.
Shema cepljenja, ki se uporablja za cepivo Synflorix, je odvisna od starosti otroka in mora temeljiti na uradnih priporočilih.
The vaccination schedule should be completed at least 4 weeks before the start of laying.
Program cepljenja bi se moral zaključiti vsaj 4 tedne pred začetkom obdobja nesenosti.
The vaccination schedule to be used depends on the age of the child and should be based on official recommendations.
Shema cepljenja, ki se bo uporabila, je odvisna od starosti otroka in mora temeljiti na uradnih priporočilih.
The vaccination schedules of two doses administered with an interval of one or two months showed similar immune responses in both adults and adolescents.
Shema cepljenja z dvema odmerkoma in eno- ali dvomesečnim presledkom je pokazal podobne imunske odzive v obeh študijah pri odraslih in mladostnikih.
The vaccine (1 ml liquid) will be given orally.
Otrok bo cepivo (1 ml tekočine) prejel peroralno (skozi usta).
The vaccine also contains an ‘adjuvant’ (a compound called saponin) to stimulate a better response.
Cepivo vsebuje tudi adjuvans (spojino saponin) za stimulacijo boljšega odziva.
The vaccine also contains an ‘adjuvant’ (a compound containing aluminium) to stimulate a better protective immune response.
Cepivo vsebuje tudi „adjuvans“ (spojino, ki vsebuje aluminij) za stimulacijo boljšega zaščitnega imunskega odziva.
The vaccine also contains an ‘adjuvant’ (a compound containing aluminium) to stimulate a better response.
Cepivo vsebuje tudi adjuvans (spojino, ki vsebuje aluminij) za spodbujanje boljšega odziva.
The vaccine also contains an ‘adjuvant’ (a compound containing aluminium) to stimulate a better response.
Cepivo vsebuje tudi „adjuvans“ (spojino, ki vsebuje aluminij) za stimulacijo boljšega odziva.
The vaccine also contains an ‘adjuvant’ (a compound containing oil) to enhance the immune response.
Cepivo vsebuje tudi „adjuvans“ (spojino, ki vsebuje olje) za spodbujanje imunskega odziva.
The vaccine also contains an ‘adjuvant’ (a compound containing oil) to stimulate a better response.
Cepivo vsebuje tudi „adjuvans“ (spojino, ki vsebuje olje) za stimulacijo boljšega odziva.
The vaccine also contains an ‘adjuvant’ (liquid paraffin) to stimulate a better response.
Cepivo vsebuje tudi adjuvans (tekoči parafin) za stimulacijo boljšega odziva.
The vaccine also contains an ‘adjuvant’ (liquid paraffin) to stimulate a better response.
Cepivo vsebuje tudi „adjuvans“ (tekoči parafin) za spodbujanje boljšega odziva.
The vaccine also contains an ‘adjuvant’ (mineral oil) to stimulate a better response.
Cepivo vsebuje tudi „adjuvans“ (mineralno olje) za spodbujanje boljšega odziva.
The vaccine also contains an ‘adjuvant’ to enhance the immune response.
Cepivo vsebuje tudi adjuvans za povečanje imunskega odziva.
The vaccine also contains an ‘adjuvant’ to enhance the immune response.
Cepivo vsebuje tudi „adjuvans“ za povečanje imunskega odziva.
The vaccine also contains an ‘adjuvant’ to enhance the immune response.
Cepivo vsebuje tudi „adjuvans“ za spodbuditev imunskega odziva.
The vaccine also contains an ‘adjuvant’ to stimulate a better immune response.
Cepivo vsebuje tudi „adjuvans“, ki spodbudi boljši imunski odziv.
The vaccine also contains an ‘adjuvant’, a compound containing aluminium to stimulate a better response.
Cepivo vsebuje tudi adjuvans (spojino, ki vsebuje aluminij) za spodbujanje boljšega odziva.
The vaccine also contains ‘adjuvants’ (a compound containing aluminium as well as mineral oil, an emulsifier and a detergent) to stimulate a better response.
Cepivo vsebuje tudi adjuvans (spojino, ki vsebuje aluminij, mineralno olje, emulgator in detergent) za stimulacijo boljšega odziva.
The vaccine also contains ‘adjuvants’ (aluminium hydroxide and saponin) that enhance the response of the immune system.
Cepivo vsebuje tudi „adjuvansa“ (aluminijev hidroksid in saponin) za povečanje imunskega odziva.
The vaccine also contains ‘adjuvants’ (aluminium hydroxide and saponin) to enhance the immune response.
Cepivo vsebuje tudi „adjuvansa“ (aluminijev hidroksid in saponin) za povečanje imunskega odziva.
The vaccine also contains ‘adjuvants’ (aluminium hydroxide and saponin) to enhance the immune response.
Cepivo vsebuje tudi „adjuvanse“ (aluminijev hidroksid in saponin) za povečanje imunskega odziva.
The vaccine also contains ‘adjuvants’ (aluminium hydroxide and saponin) to stimulate a better reaction by the immune system.
Cepivo vsebuje tudi „adjuvans“ (aluminijev hidroksid in saponin) za boljši odziv imunskega sistema.
The vaccine also contains ‘adjuvants’ (aluminium hydroxide and saponin) to stimulate a better response.
Cepivo vsebuje tudi „adjuvansa“ (aluminijev hidroksid in saponin) za spodbujanje boljšega odziva.
The vaccine also contains ‘adjuvants’ to stimulate a better response.
Cepivo vsebuje tudi „adjuvanse“ za spodbujanje boljšega odziva.
The vaccine bottle should be shaken gently and the vaccine suspension should then be added to the buffer solution and mixed well to obtain a colourless slightly opalescent solution.
Steklenico s cepivom je treba stresati previdno, suspenzijo cepiva pa je treba dodati pufrski raztopini in dobro premešati, da bi dobili brezbarvno, rahlo opalescentno raztopino.
The vaccine can be administered to 7-day and older chickens by drinking water.
Piščancem, starejšim od sedem dni, se lahko cepivo daje v vodo za pitje.
The vaccine can be administered to 7-day and older chickens by drinking water.
Sedemdnevnim in starejšim piščancem dajemo cepivo v vodi za pitje.
The vaccine can be administered to 7-day and older chickens by drinking water.
Sedemdnevnim in starejšim piščancem ga lahko dajemo v vodo za pitje.
The vaccine can be given after you have recovered.
Cepili se boste lahko/vaš otrok se bo lahko cepil, ko boste ozdraveli/bo vaš otrok ozdravel.
The vaccine can be given to one-day-old chicks as a single injection under the skin or directly into 18-day-old eggs containing embryos (unhatched developing
Cepivo se lahko uporablja pri en dan starih piščancih v obliki enkratnega
The vaccine can be injected subcutaneously (SC) or intramuscularly (IM), preferably in the deltoid region (see sections 4.8 and 5.1).
Cepivo se lahko injicira subkutano (s.c.) ali intramuskularno (i.m.), po možnosti v deltoidni predel (glejte poglavji 4.8 in 5.1).
The vaccine can be used during lactation.
Cepivo se lahko uporablja v obdobju laktacije.
The vaccine can be used during pregnancy and lactation.
Lahko se uporablja v obdobju brejosti in laktacije.
The vaccine can be used during pregnancy and lactation.
LLahko se uporablja v obdobju brejosti in laktacije.
The vaccine can be used during pregnancy.
Lahko se uporablja v obdobju brejosti.
The vaccine can be used together with Tetanus-Serum from Intervet for treatment of injured horses that have not been immunised against tetanus.
Cepivo lahko uporabljamo hkrati z Intervetovim Tetanus-Serumom za zdravljenje poškodovanih konj, ki niso bili cepljeni proti tetanusu.
The vaccine can only be expected to protect against influenza caused by A/California/07/2009 (H1N1)v- like strains.
Pričakuje se, da cepivo ščiti le pred gripo, ki jo povzročijo sevi, podobni A/California/07/2009 (H1N1)v.
The vaccine can reduce the severity of symptoms caused by acute (short-lived) babesiosis (the disease caused by infection with B. canis, with weakness, fever and jaundice) and anaemia (low red blood cell counts).
Cepivo lahko zmanjša resnost simptomov, ki jih povzročata akutna (kratkotrajna) babezioza (bolezen, ki jo povzroča okužba z B. canis in jo spremljajo šibkost, povišana telesna temperatura in zlatenica) in anemija (nizka koncentracija rdečih krvnih celic).
The vaccine cannot cause the diseases that it protects your child from.
Cepivo ne more povzročiti bolezni, pred katerimi ščiti vašega otroka.
The vaccine complies with the WHO recommendation (northern hemisphere) and EU decision for the 2015/2016 season.
Cepivo je v skladu s priporočili SZO (za severno poloblo) in z odločbo EU za sezono 2015/2016.
The vaccine contains 10 doses of 0.5 ml.
Cepivo vsebuje 10 odmerkov po 0,5 ml.
The vaccine contains 11.3 micrograms thiomersal.
Cepivo vsebuje 11,3 mikrograma tiomersala.
The vaccine contains 5 micrograms thiomersal (see section 4.4).
Cepivo vsebuje 5 mikrogramov tiomersala (glejte poglavje 4.4).
The vaccine contains a flu strain called ‘A/Indonesia/05/2005 PR8-IBCDC- RG2’ (H5N1).
Cepivo vsebuje sev gripe, imenovan ‘A/Indonesia/05/2005 PR8-IBCDC-RG2’ (H5N1).
The vaccine contains a flu strain called ‘A/VietNam/1194/2004 NIBRG 14’ (H5N1).
Cepivo vsebuje sev gripe, imenovan „A/VietNam/1194/2004 NIBRG 14“ (H5N1).
The vaccine contains an inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 ORF2 protein and inactivated Mycoplasma hyopneumoniae.
Cepivo vsebuje inaktiviran rekombinanten prašičji cirko virus tip I z izraženim proteinom ORF2 prašičjega cirkovirusa tipa 2 in inktivirano Mycoplasmo hyopneumoniae.
The vaccine contains an ‘adjuvant’ (a compound containing oil) to enhance the immune response.
Cepivo vsebuje tudi „adjuvans“ (spojino, ki vsebuje olje) za povečanje imunskega odziva.
The vaccine contains an ‘adjuvant’ (a compound containing squalene) to stimulate a better response.
Cepivo vsebuje „adjuvans“ (spojino, ki vsebuje skvalen) za spodbujanje boljšega odziva.
The vaccine contains an ‘adjuvant’ (MF59C.1) to stimulate a better response.
Cepivo vsebuje "adjuvans" (MF59C.1) za spodbujanje boljšega odziva.
The vaccine contains an ‘adjuvant’ AS03 to stimulate a better response.
Cepivo vsebuje »adjuvans« (AS03), ki spodbuja boljši odziv.
The vaccine contains an ‘adjuvant’ AS03.
Cepivo vsebuje "adjuvans" AS03.
The vaccine contains an ‘adjuvant’ AS03.
Cepivo vsebuje »adjuvans« (AS03).
The vaccine contains inactivated Bluetongue Virus Serotype 1 with aluminium hydroxide and saponin adjuvants.
Cepivo vsebuje inaktiviran virus bolezni modrikastega jezika, serotip 1, z aluminijevim hidroksidom in saponinom kot dodatkoma.
The vaccine contains inactivated Bluetongue virus serotype 8 with aluminium hydroxide and saponin adjuvants.
Cepivo vsebuje inaktiviran virus modrega jezika, serotip 8, z aluminijevim hidroksidom in saponini kot adjuvansoma.
The vaccine contains inactivated bluetongue virus serotypes 2 and 4 with aluminium hydroxide and saponin adjuvants.
Cepivo vsebuje inaktiviran virus modrikastega jezika, serotip 2 in 4, z aluminijevim hidroksidom in saponini kot dodatki.
The vaccine contains inactivated Bluetongue Virus with aluminium hydroxide and saponin adjuvants.
Cepivo vsebuje inaktiviran virus bolezni modrikastega jezika, z aluminijevim hidroksidom in saponinom kot dodatkoma.
The vaccine contains per 0.5ml 9.75 mg squalene, 1.175 mg polysorbate 80 and 1.175 mg sorbitan trioleate.
Cepivo vsebuje na 0,5 ml 9,75 mg skvalena, 1,175 mg polisorbata 80 in 1,175 mg sorbitantrioleata.
The vaccine contains phase I Coxiella burnetii as active ingredient inducing active immunity against Q fever in cattle and goats.
Cepivo vsebuje Fazo I Coxiella burnetii kot aktivno učinkovino, ki stimulira aktivno imunost proti Q-mrzlici pri govedu in kozah.
The vaccine contains small amounts of a protein from PCV2 and whole Mycoplasma hyopneumoniae bacteria that have been killed (inactivated) so that they do not cause disease.
Cepivo vsebuje manjše količine beljakovine iz prašičjega cirkovirusa tipa 2 in cele bakterije Mycoplasma hyopneumoniae, ki so mrtve (inaktivirane), tako da ne povzročajo bolezni.
The vaccine contains ‘surface antigens’ from three different strains (types) of influenza (flu) virus: A/California/7/2009 (H1N1)pdm09-like strain; A/Switzerland/9715293/2013 (H3N2)–like strain; and B/Phuket/3073/2013-like strain.
Vsebuje površinske antigene treh različnih sevov (vrst) virusa influence (gripe): sev, podoben sevu A/California/7/2009 (H1N1)pdm09; sev, podoben sevu A/Switzerland/9715293/2013 (H3N2) in sev, podoben sevu B/Phuket/3073/2013.
The vaccine does not contain any live bacteria or viruses and it cannot cause any of the infectious diseases against which it protects.
Cepivo ne vsebuje živih bakterij ali virusov in ne more povzročiti nalezljivih bolezni, proti katerim ščiti.
The vaccine does not contain any live PCV2 and the antigen cannot replicate in the animal.
Cepivo ne vsebuje živega virusa PCV2, antigen pa se v živali ne more razmnoževati.
The vaccine effectiveness against Hib invasive disease of DTaP and Hib combination vaccines (pentavalent and hexavalent including vaccines containing the Hib antigen from Hexacima) has been demonstrated in Germany via an extensive (over five years follow-up period) post-marketing surveillance study.
Učinkovitost kombiniranih cepiv proti DTaP in Hib (pentavalentna in heksavalentna cepiva, vključno s cepivi, ki vsebujejo enak antigen Hib kot cepivo Hexacima) proti invazivnim boleznim, ki jih povzroča Hib, so dokazali v Nemčiji z obširno (več kot petletno obdobje spremljanja) post marketinško opazovalno študijo.
The vaccine effectiveness against Hib invasive disease of DTaP and Hib combination vaccines (pentavalent and hexavalent including vaccines containing the Hib antigen from Hexyon) has been demonstrated in Germany via an extensive (over five years follow-up period) post-marketing surveillance study.
Učinkovitost kombiniranih cepiv proti DTaP in Hib (pentavalentna in heksavalentna cepiva, vključno s cepivi, ki vsebujejo enak antigen Hib kot cepivo Hexyon) proti invazivnim boleznim, ki jih povzroča Hib, so dokazali v Nemčiji z obširno (več kot petletno obdobje spremljanja) post marketinško opazovalno študijo.
The vaccine has been authorised under ‘exceptional circumstances’.
Cepivo je bilo odobreno v „izjemnih okoliščinah“.
The vaccine has been demonstrated to provide protection against QX-like variant.
Pokazalo se je, da cepivo zagotavlja zaščito proti QX podobni različici.
The vaccine has been shown reduce virus shedding in infected ducks.
Dokazano je bilo tudi, da cepivo zmanjša izločanje virusa pri okuženih racah.
The vaccine has been shown to prevent clinical signs and mortality and reduce virus shedding in infected chickens and ducks.
Dokazano je bilo, da cepivo preprečuje klinične znake in umrljivost ter zmanjšuje izločanje virusa pri okuženih piščancih in racah.
The vaccine has been shown to prevent clinical signs and mortality and reduce virus shedding in infected chickens.
Dokazano je bilo, da cepivo preprečuje klinične znake in umrljivost ter zmanjšuje izločanje virusa pri okuženih piščancih.
The vaccine has been shown to reduce clinical signs and mortality and reduce virus shedding in infected chickens.
Dokazano je bilo, da cepivo zmanjša klinične znake in umrljivost ter zmanjšuje izločanje virusa pri okuženih piščancih.
The vaccine has not been studied in subjects with impaired immunity.
Cepiva pri osebah s pomanjkljivo imunostjo niso preučevali.
The vaccine helps to reduce the signs of these diseases.
Cepivo pripomore k zmanjšanju znakov teh bolezni.
The vaccine helps to reduce the symptoms of the diseases and also helps to reduce viral excretion in case of calicivirus infection.
Cepivo zmanjša simptome bolezni in zmanjša izločanje virusov pri kalicivirozi.
The vaccine helps to reduce the symptoms of the diseases and helps to reduce viral excretion in case of calicivirus infection.
Cepivo pripomore k zmanjšanju simptomov bolezni in k zmanjšanje izločanja virusov pri okužbi s kalicivirusi.
The vaccine induces active immunity against infectious laryngotracheitis and Marek’s disease in chickens.
Cepivo spodbudi aktivno imunost proti kužnemu laringotraheitisu in Marekovi bolezni pri piščancih.
The vaccine induces an active immunity and a serological response against Infectious Bursal Disease and Marek’s Disease in chickens.
Cepivo spodbudi aktivno imunost in serološki odgovor proti bolezni Gumboro in Marekovi bolezni pri piščancih.
The vaccine is a clear to opalescent suspension.
Cepivo je bistra do opalescentna suspenzija.
The vaccine is a homogeneous white suspension.
Cepivo je homogena bela suspenzija.
The vaccine is a homogeneous white suspension.
Cepivo je homogena, bela suspenzija.
The vaccine is a live recombinant E2 gene deleted Bovine Viral Diarrhoea Virus containing Classical Swine Fever E2.
Cepivo je živi rekombinatni virus goveje virusne driske z izbrisanim genom E2, ki vsebuje gen E2 klasične prašičje kuge.
The vaccine is a whitish suspension supplied in a bottle.
Cepivo je belkasta suspenzija, ki je na voljo v steklenicah.
The vaccine is a whitish suspension supplied in a single-dose glass bottle.
Cepivo je belkasta suspenzija, ki je na voljo v steklenicah z enim odmerkom.
The vaccine is able to induce antibodies in a wide range of birds.
Cepivo je sposobno spodbuditi nastajanje protiteles pri številnih vrstah ptic.
The vaccine is able to induce antibodies in a wide range of birds.
Cepivo spodbudi nastajanje protiteles pri številnih vrstah ptic.
The vaccine is administered directly from the tip of the syringe onto the opening of the nostril and enters the nasal cavity during inhalation.
Cepivo je treba vbrizgati neposredno s konice brizge na nosno odprtino, od koder pri vdihu steče v nosno votlino.
The vaccine is also effective against Marek’s disease.
Cepivo je učinkovito tudi proti Marekovi bolezni.
The vaccine is also used to reduce loss of daily weight gain and mortality associated with PV2 infection.
Prav tako se uporablja za zmanjšanje izgube dnevnega prirasta telesne mase in umrljivosti, povezanih z okužbo s prašičjim cirkovirusom tipa 2 (PCV2).
The vaccine is also ‘adsorbed’ (fixed) onto an aluminium compound to enhance the immune response.
Cepivo je tudi „adsorbirano“ (vezano) na površino aluminijeve spojine, kar spodbudi boljši imunski odziv.
The vaccine is also ‘adsorbed’ (fixed) onto an aluminium compound to stimulate a better response.
Cepivo je tudi adsorbirano (vezano) na površino aluminijeve spojine, kar spodbudi boljši odziv.
The vaccine is also ‘adsorbed’ (fixed) onto an aluminium compound to stimulate a better response.
Cepivo je tudi „adsorbirano“ (vezano) na površino aluminijeve spojine, kar spodbudi boljši odziv.
The vaccine is available as a suspension for injection and can only be obtained with a prescription.
Cepivo je na voljo v obliki suspenzije za injiciranje in se izdaja le na recept.
The vaccine is for intramuscular use only.
To cepivo je namenjeno samo za intramuskularno uporabo.
The vaccine is given according to official recommendations.
Cepivo se daje le v skladu z uradnimi priporočili.
The vaccine is given by injection into a muscle.
Cepivo se daje z injiciranjem v mišico.
The vaccine is given by injection into the thigh muscle in infants or into the shoulder muscle in young children.
Cepivo se daje z injekcijo v stegensko mišico dojenčkov ali ramensko mišico pri majhnih otrocih.
The vaccine is given by injection into the thigh muscle in infants, or into the upper arm muscle in young children.
Cepivo se daje z injekcijo v stegensko mišico pri dojenčkih ali mišico nadlakti pri majhnih otrocih.
The vaccine is given to fattening pigs from three weeks of age as a single injection into the skin at the side of the neck, along the back or in the hind leg.
Cepivo se daje pitancem od tretjega tedna starosti naprej z enkratnim injiciranjem v kožo na stranskem delu vratu, hrbtu ali zadnji nogi.
The vaccine is given to female pigs before and/or during pregnancy.
Cepivo se daje samicam pred in/ali med brejostjo.
The vaccine is given to pigs from three weeks of age as a single injection into the muscle in the neck behind the ear.
Cepivo se daje prašičem, starejšim od treh tednov, kot enkratna injekcija v mišico v vrat za uho.
The vaccine is given to pigs from three weeks of age as a single injection into the neck muscle.
Cepivo se daje prašičem od treh tednov starosti naprej z enkratnim injiciranjem v vratno mišico.
The vaccine is given to rabbits from 30 days of age as a single injection under the skin of the side of the chest.
Cepivo se daje kuncem, starejšim od 30 dni, kot enkratna injekcija pod kožo na strani prsnega koša.
The vaccine is given to young animals as two injections into the muscle.
Cepivo se mladičem injicira v mišico v dveh odmerkih.
The vaccine is given to young animals from two and a half months of age onwards as two injections administered subcutaneously with an interval of three weeks.
Cepivo se injicira subkutano mladim živalim od starosti 2,5 meseca dalje v dveh odmerkih s tritedenskim presledkom.
The vaccine is intended for the active immunisation of healthy puppies and dogs against disease caused by canine parainfluenza virus.
Cepivo je namenjeno aktivni imunizaciji pasjih mladičev in odraslih psov proti boleznim, ki jih povzročajo virus pasje kuge, pasji parvovirus, pasji adenovirus tipa 1 in 2 in virus pasje parainfluence.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine distemper virus, canine parvovirus, canine adenovirus type 1 and 2, canine parainfluenza virus, Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola servar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa and Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie.
Cepivo je namenjeno aktivni imunizaciji zdravih pasjih mladičev in odraslih psov proti boleznim, ki jih povzročajo virus pasje kuge, pasji parvovirus, pasji adenovirus tipa 1 in 2, virus pasje parainfluence, Leptospira interrogans serološka skupina Australis serovar Bratislava, Leptospira interrogans serološka skupina Canicola serovar Canicola, Leptospira kirschneri serološka skupina Grippotyphosa serovar Grippotyphosa, Leptospira interrogans serološka skupina Icterohaemorrhagiae serovar Icterohaemorrhagiae.